PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay
Abstract Background Programmed death ligand 1 (PD-L1) has shown potential as a therapeutic target in numerous solid tumors. Its prognostic significance has also been established in pancreatic ductal adenocarcinoma (PDAC). The present study aimed to explore PD-L1 expression in PDAC cases in a large C...
Main Authors: | Xiaolong Liang, Jian Sun, Huanwen Wu, Yufeng Luo, Lili Wang, Junliang Lu, Zhiwen Zhang, Junchao Guo, Zhiyong Liang, Tonghua Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-017-0678-4 |
Similar Items
-
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017-05-01) -
Features of immunophenotype of pancreatic ductal adenocarcinoma
by: A. V. Evseyev
Published: (2014-12-01) -
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
by: Zoe C. Schmiechen, et al.
Published: (2021-01-01) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01) -
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
by: Yiyin Zhang, et al.
Published: (2019-08-01)